Panakeia has been selected as a Top 10 Finalist in the AI for Good for the @EmpactVentures & @HaysTeOct 5, 2022 See us pitch live to win 12th October. Register to attend
Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium
Panakeia launches PANProfiler Colon, an AI-driven tool for precision medicine in colon cancerPANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samples Entirely digital, AI-driven molecular profiling...